NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: University Hospital, Tours
Conditions: Memory Disorders
Interventions: New memory assessment
Countries: France
Episodic memory (EM) is a neuropsychological marker of Alzheimer's disease (AD) (Thomas-Anterion, 2006). Current tests for its assessment do not take into account the identity and emotional aspects of memory (Van der Linden et al., 2018). However, there are models that integrate links with identity, self-awareness and experience. Pause et al. (2013) propose criteria to create ecological tools, including consideration of the emotional valence of memories and the spatio-temporal context of acquisition. In line with these criteria, we have developed a new tool: the NEM (New evaluation of Episodic Memory). Preliminary studies show different response profiles on the NEM among patients (Launay et al., 2023). We now want to evaluate the relevance of this tool in the differential diagnosis of AD.
Sex: ALL
Age: 50 Years to —
Healthy volunteers: No
Study type: OBSERVATIONAL
Inclusion Criteria: * Age ≥ 50 years * Ability to understand judged sufficient by the assessor; * Amnesic MCI profile (Petersen, 2003) during the 1st medical consultation prior to the assessment being prescribed. Exclusion Criteria: * Severe auditory and/or visual sensory impairment not compatible with neuropsychological assessment; * Judged fit to take the test by the assessor; * Patient under guardianship, curatorship or family guardianship; * Opposition to data processing.
- Tours, France